Accelerated Rotational Field Deep TMS for Treating OCD
ConditionObsessive-Compulsive Disorder
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorBen-Gurion University of the Negev
About this trial
A Prospective Double Blind Randomized Controlled Trial to Evaluate the Efficacy and Durability of the BrainsWay Rotational Field Deep Transcranial Magnetic Stimulation (Deep TMS) in Obsessive-Compulsive Subjects
Eligibility criteria
Qualifiers
Outpatients
Diagnosed as suffering from OCD according to the DSM-V.
Subjects with a YBOCS score of >20.
If on SRI, patient must be maintained on current dosages (with or without additional antidepressant or psychotropic augmentation for treatment of OCD), at a stable therapeutic dosage for at least 2 months prior to study entry and for the duration of the trial.
Disqualifiers
Subjects diagnosed as suffering from any other Axis I diagnosis as the primary diagnosis.
Comorbid, secondary psychiatric diagnoses are unstable and are likely to require changes in therapeutic regimens even if OCD improves.
Present suicidal risk as assessed by the investigator using the Columbia Suicide Severity Rating Scale, brief mental status exam and psychiatric interview or a history of attempted suicide in the past year.
History of epilepsy or seizure (EXCEPT those therapeutically induced by ECT and febrile seizures in infancy).
Trial design
Treatments tested in this trial
- BrainsWay Deep TMS HAC/H7-Coil
- BrainsWay Deep TMS Sham Coil
Treatment groups
50 Participants
are divided into 2 treatment groupsSponsors and collaborators
Ben-Gurion University of the Negev
Lead sponsor
Brainsway
Collaborator
Source ClinicalTrials.gov